Price T Rowe Associates Inc Pacific Biosciences Of California, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,838,752 shares of PACB stock, worth $3.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,838,752

Previous 1,939,234 5.18%

Holding current value

$3.62 Million

Previous $2.66 Million 17.69%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.2 - $2.17 $120,578 - $218,045	-100,482 Reduced 5.18%	1,838,752 $3.13 Million
Q2 2024 Aug 14, 2024	SELL	$1.36 - $3.65 $21,961 - $58,940	-16,148 Reduced 0.83%	1,939,234 $2.66 Million
Q1 2024 May 15, 2024	SELL	$3.52 - $9.59 $5.79 Million - $15.8 Million	-1,643,893 Reduced 45.67%	1,955,382 $7.33 Million
Q4 2023 Feb 14, 2024	SELL	$5.97 - $10.36 $2.32 Million - $4.03 Million	-389,435 Reduced 9.76%	3,599,275 $35.3 Million
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $813,025 - $1.38 Million	98,788 Added 2.54%	3,988,710 $33.3 Million
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $2.47 Million - $3.49 Million	248,110 Added 6.81%	3,889,922 $51.7 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $1.72 Million - $2.6 Million	216,045 Added 6.31%	3,641,812 $42.2 Million
Q4 2022 Feb 14, 2023	BUY	$5.67 - $11.2 $312,638 - $617,556	55,139 Added 1.64%	3,425,767 $28 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $8.57 $27.2 Million - $59.2 Million	-6,913,462 Reduced 67.22%	3,370,628 $19.6 Million
Q2 2022 Aug 15, 2022	BUY	$4.02 - $10.43 $16.8 Million - $43.6 Million	4,179,997 Added 68.48%	10,284,090 $45.5 Million
Q1 2022 May 16, 2022	BUY	$8.43 - $20.9 $2.28 Million - $5.65 Million	270,289 Added 4.63%	6,104,093 $55.5 Million
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $1.63 Million - $2.54 Million	84,468 Added 1.47%	5,833,804 $118 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $55.1 Million - $77.6 Million	2,214,524 Added 62.65%	5,749,336 $145 Million
Q2 2021 Aug 16, 2021	SELL	$22.3 - $36.02 $122,360 - $197,641	-5,487 Reduced 0.15%	3,534,812 $124 Million
Q1 2021 May 17, 2021	BUY	$26.38 - $51.15 $5.84 Million - $11.3 Million	221,559 Added 6.68%	3,540,299 $118 Million
Q4 2020 Feb 16, 2021	BUY	$10.5 - $28.5 $34.8 Million - $94.6 Million	3,318,740 New	3,318,740 $86.1 Million

Others Institutions Holding PACB

# of Institutions

254

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $443M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Pacific Biosciences Of California, Inc. Transaction History